IO Biotech, Inc. (IOBT)
USD 0.77
(0.84%)
USD 0.77
(0.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -71.73 Million | -59.72 Million | -40.64 Million | -9.95 Million | -8.89 Million |
| Net Income | -86.08 Million | -71.45 Million | -67.87 Million | -12.04 Million | -10.74 Million |
| Depreciation & Amortization | 756 Thousand | 540 Thousand | 2000.00 | - | - |
| Deferred income taxes | 126 Thousand | 87 Thousand | -2000.00 | - | - |
| Stock-based compensation | 8.05 Million | 7.04 Million | 1.79 Million | 64 Thousand | 131 Thousand |
| Change in working capital | 5.86 Million | 4.19 Million | -776 Thousand | 148 Thousand | 893 Thousand |
| Other non-cash items | -457 Thousand | -130 Thousand | 26.21 Million | 1.87 Million | 828 Thousand |
| Investing Cash Flow | -323 Thousand | -690 Thousand | -153 Thousand | - | - |
| Investments in PPE | -323 Thousand | -690 Thousand | -153 Thousand | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 71.86 Million | - | 252.95 Million | 5.1 Million | 9.01 Million |
| Debt repayment | - | - | - | - | -9.01 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 71.86 Million | - | 115.11 Million | 5.1 Million | - |
| Other Financing Activities | -3.19 Million | - | 137.83 Million | -14 Thousand | 18.02 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -126 Thousand | 77 Thousand | 3.4 Million | -475 Thousand | 103 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 5.98 Million | 4.11 Million | -4.18 Million | 623 Thousand | 790 Thousand |
| Cash at beginning of period | 142.59 Million | 211.79 Million | 3.4 Million | 7.84 Million | 7.97 Million |
| Cash at end of period | 143.19 Million | 142.85 Million | 211.79 Million | 3.4 Million | 7.84 Million |
| Capital Expenditure | -323 Thousand | -690 Thousand | -153 Thousand | - | - |
| Effect of forex changes on cash | 803 Thousand | -8.52 Million | -3.75 Million | 413 Thousand | -248 Thousand |
| Net cash flow / Change in cash | 603 Thousand | -68.94 Million | 208.39 Million | -4.44 Million | -125 Thousand |
| Free Cash Flow | -72.06 Million | -60.41 Million | -40.79 Million | -9.95 Million | -8.89 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.68 Million | -19.45 Million | -26.18 Million | -86.08 Million | -21.67 Million | -21.17 Million |
| Depreciation & Amortization | 214 Thousand | 211 Thousand | 201 Thousand | 756 Thousand | 194 Thousand | 187 Thousand |
| Deferred income taxes | - | - | -4.72 Million | 126 Thousand | -21.33 Million | -21.18 Million |
| Stock-based compensation | 1.64 Million | 1567.00 | 1558.00 | 8.05 Million | 2989.00 | 1624.00 |
| Change in working capital | 1.75 Million | -7.71 Million | 2.03 Million | 5.86 Million | 2.16 Million | 1.11 Million |
| Other non-cash items | 984 Thousand | 2.48 Million | 4.32 Million | -457 Thousand | 21.67 Million | 21.17 Million |
| Investing Cash Flow | -12 Thousand | -11 Thousand | -112 Thousand | -323 Thousand | -24 Thousand | -39 Thousand |
| Investments in PPE | -12 Thousand | -11 Thousand | -112 Thousand | -323 Thousand | -24 Thousand | -39 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | -10 Thousand | 71.86 Million | 71.87 Million | -2.74 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -10 Thousand | 71.86 Million | 71.87 Million | - |
| Other Financing Activities | - | - | -10 Thousand | -3.19 Million | 71.87 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.17 Million | -38 Thousand | -2.76 Million | -126 Thousand | 2.18 Million | 204 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 580 Thousand | -7.67 Million | 4.8 Million | 5.98 Million | -17 Thousand | 911 Thousand |
| Cash at beginning of period | 117.98 Million | 143.19 Million | 165.5 Million | 142.59 Million | 110.36 Million | 128.79 Million |
| Cash at end of period | 100.74 Million | 117.98 Million | 143.19 Million | 143.19 Million | 165.76 Million | 110.36 Million |
| Capital Expenditure | -12 Thousand | -11 Thousand | -112 Thousand | -323 Thousand | -24 Thousand | -39 Thousand |
| Effect of forex changes on cash | -241 Thousand | -268 Thousand | 609 Thousand | 803 Thousand | -450 Thousand | -131 Thousand |
| Net cash flow / Change in cash | -17.23 Million | -25.21 Million | -22.3 Million | 603 Thousand | 55.4 Million | -18.43 Million |
| Free Cash Flow | -16.99 Million | -24.94 Million | -22.9 Million | -72.06 Million | -16.01 Million | -18.3 Million |
OSCUF
VST
AGRITECH
5994
4707
KBNT